BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1546388)

  • 1. Relative performance of specific and nonspecific fluorescence polarization immunoassay for cyclosporine in transplant patients.
    Chan GL; Weinstein SS; LeFor WW; Spoto E; Kahana L; Shires DL
    Ther Drug Monit; 1992 Feb; 14(1):42-7. PubMed ID: 1546388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a monoclonal antibody fluorescent polarization immunoassay with monoclonal antibody radioimmunoassay for cyclosporin determination in whole blood.
    Alvarez JS; Sacristan JA; Alsar MJ
    Ther Drug Monit; 1992 Feb; 14(1):78-80. PubMed ID: 1546394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the monoclonal fluorescence polarization immunoassay for cyclosporine specific? Comparison with specific radioimmunoassay.
    Armijo JA; Navarro FA; Angeles de Cos M
    Ther Drug Monit; 1992 Aug; 14(4):333-8. PubMed ID: 1519309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of four different cyclosporine immunoassays in heart and kidney transplant recipients.
    Hesse CJ; Baan CC; Daane R; Stolk BJ; Jutte NH; Hendriks GF; Weimar W
    Ther Drug Monit; 1990 Nov; 12(6):547-53. PubMed ID: 2275000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerable lack of agreement between S-FPIA and EMIT cyclosporine assay in therapeutic drug monitoring, of heart transplant recipients.
    Regazzi MB; Molinaro M; Tinelli C; D'Eril GM; Goggi C; Campana C; Fiorito V; Moratti R; Viganò M
    Ther Drug Monit; 2000 Dec; 22(6):712-5. PubMed ID: 11128239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal fluorescence polarization immunoassay evaluated for monitoring cyclosporine in whole blood after kidney, heart, and liver transplantation.
    Winkler M; Schumann G; Petersen D; Oellerich M; Wonigeit K
    Clin Chem; 1992 Jan; 38(1):123-6. PubMed ID: 1733584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine A monitoring in patients with renal, cardiac, and liver transplants: a comparison between fluorescence polarization immunoassay and two different RIA methods.
    Bergan S; Rugstad HE; Stokke O; Bentdal O; Frøysaker T; Bergan A
    Scand J Clin Lab Invest; 1993 Aug; 53(5):471-7. PubMed ID: 8210969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of nonspecific radioimmunoassay, high-performance liquid chromatography, and fluorescence polarization immunoassay for cyclosporine monitoring in renal transplantation.
    Lee SF; Yang WC; Shann TY; Lui WY; Wang RB
    Ther Drug Monit; 1991 Mar; 13(2):152-6. PubMed ID: 2053123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific monoclonal radioimmunoassay and fluorescence polarization immunoassay for trough concentration and area-under-the-curve monitoring of cyclosporine in renal transplantation.
    Lindholm A; Napoli K; Rutzky L; Kahan BD
    Ther Drug Monit; 1992 Aug; 14(4):292-300. PubMed ID: 1519303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of instrumental, nonisotopic immunoassays (fluorescence polarization immunoassay and enzyme-multiplied immunoassay technique) for cyclosporine monitoring in whole blood after kidney and liver transplantation.
    Beutler D; Molteni S; Zeugin T; Thormann W
    Ther Drug Monit; 1992 Oct; 14(5):424-32. PubMed ID: 1448852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical correlations of cyclosporine-specific and -nonspecific assays in stable renal transplants, acute rejection, and cyclosporine nephrotoxicity.
    Schroeder TJ; Sridhar N; Pesce AJ; Alexander JW; First MR
    Ther Drug Monit; 1993 Jun; 15(3):190-4. PubMed ID: 8332997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of cyclosporine by liquid chromatography and three immunoassays in blood from liver, cardiac, and renal transplant recipients.
    McBride JH; Kim SS; Rodgerson DO; Reyes AF; Ota MK
    Clin Chem; 1992 Nov; 38(11):2300-6. PubMed ID: 1424128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FPIA and EMIT methods compared for cyclosporine monitoring in heart transplant patients.
    Fatio R; Sütsch G; Pei P; Follath F; Kiowski W
    Clin Chem; 1998 Mar; 44(3):693-4. PubMed ID: 9510894
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative analyses of cyclosporine in whole blood and plasma by radioimmunoassay, fluorescence polarization immunoassay, and high-performance liquid chromatography.
    Lindholm A; Henricsson S
    Ther Drug Monit; 1990 Jul; 12(4):344-52. PubMed ID: 2396308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion of cardiac and liver transplant recipients from HPLC and FPIA (polyclonal) to an FPIA (monoclonal) technique for measurement of blood cyclosporin A.
    McBride JH; Kim S; Rodgerson DO; Reyes A
    J Clin Lab Anal; 1998; 12(6):337-42. PubMed ID: 9850184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Abbott TDx fluorescence polarization immunoassay, Sandoz radioimmunoassay, and high-performance liquid chromatography methods for the assay of serum cyclosporine.
    Schroeder TJ; Pesce AJ; Hassan FM; Wermeling JR; Warner A; Schlueter KT; First MR
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):345-7. PubMed ID: 3284078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 12-hour area under the curve cyclosporine concentrations determined by a validated liquid chromatography-mass spectrometry procedure compared with fluorescence polarization immunoassay reveals sirolimus effect on cyclosporine pharmacokinetics.
    Napoli KL
    Ther Drug Monit; 2006 Dec; 28(6):726-36. PubMed ID: 17164687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of EMIT and FPIA methods for the detection of cyclosporin A blood levels: does impaired liver function make a difference?
    Witzke O; Heemann U; Thesing A; Wolfhard U; Erhard J; Philipp T; Michel MC
    Eur J Clin Pharmacol; 1997; 52(5):413-6. PubMed ID: 9272414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine blood concentrations determined by different assay methods in heart transplant patients.
    Zylber-Katz E; Granit L
    Ther Drug Monit; 1989 Sep; 11(5):592-7. PubMed ID: 2815235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cyclosporine disposition in living related donor partial liver transplant recipients].
    Tada A; Tsuboughi S; Zenda H; Matsunami H; Ikegami T; Hashikura Y; Kitahara S; Terada M; Ishizone S; Kawasaki S
    Yakugaku Zasshi; 1993 Jan; 113(1):84-93. PubMed ID: 8463960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.